Early research (Phase 1)WithdrawnNCT02042027
What this trial is testing
Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions
Who this might be right for
Corneal NeovascularizationCorneal Graft FailureAnterior Segment Inflammation
University of Utah